Filing Details
- Accession Number:
- 0001225208-12-019254
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-07 16:11:26
- Reporting Period:
- 2012-09-07
- Filing Date:
- 2012-09-07
- Accepted Time:
- 2012-09-07 16:11:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1341069 | C Joseph Caldarella | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Svp & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Acquisiton | 2012-09-07 | 16,500 | $28.11 | 75,814 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2012-09-07 | 6,740 | $33.16 | 69,074 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2012-09-07 | 15,415 | $33.16 | 53,659 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2012-09-07 | 16,500 | $0.00 | 16,500 | $28.11 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-03-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.10 Par Value | 1,551 | Indirect | By BMY Savings & Investment Program |
Footnotes
- Shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions.
- Based on a plan statement as of the end of the most recent fiscal quarter.
- Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 2, 2004.
Billionaire Hedge Funds
